Fresenius Dialysis Device Faces FDA Scrutiny
The U.S. Food and Drug Administration on Tuesday unveiled a warning letter to Fresenius SE reprimanding the German medical supplier for making unauthorized modifications to a dialysis device following a November...To view the full article, register now.
Already a subscriber? Click here to view full article